Filters
Results 1 - 10 of 1683
Results 1 - 10 of 1683.
Search took: 0.026 seconds
Sort by: date | relevance |
Hon, L.Q.; Ganeshan, A.; Thomas, S.M.; Warakaulle, D.; Jagdish, J.; Uberoi, R., E-mail: lyequen@hotmail.com2010
AbstractAbstract
[en] Haemostatic devices can be categorised according to their mechanism of action into three main types; namely pressure devices, topical haemostatic pads and vascular closure devices (VCD). Of these three categories, it is the development of VCDs that revolutionised management of endovascular procedures. Currently available VCDs fall into three major classes, those that use a collagen plug, those that use clips and those that perform suture closure at the arteriotomy site. This article provides a comprehensive review of the all three classes with examples of commercially available devices.
Primary Subject
Source
S0720-048X(08)00527-5; Available from http://dx.doi.org/10.1016/j.ejrad.2008.09.023; Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] This paper focuses on radiologic therapeutic procedures in the vascular system which have evolved from improvements in imaging equipment and angiographic/interventional materials. 2 refs.; 7 figs
Primary Subject
Secondary Subject
Source
Wamsteker, K. (Mariastichting, Haarlem (Netherlands)); Jonas, U. (Rijksuniversiteit Leiden (Netherlands). Academisch Ziekenhuis); Veen, G. van der; Waes, P.F.G.M. van (Rijksuniversiteit Utrecht (Netherlands). Academisch Ziekenhuis) (eds.); International Congress Series; no. 747; 849 p; ISBN 0-444-80961-9;
; 1987; p. 499-508; Excerpta Medica; Amsterdam (Netherlands); DOCUMED Europe '87, 1. European conference on the applications of imaging and visual documentation in medicine; Amsterdam (Netherlands); 24-27 May 1987

Record Type
Book
Literature Type
Conference
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Marcus, M.L.; Rumberger, J.A.; Reiter, S.J.; Stanford, W.; Stark, C.A.; Feiring, A.J.
Progress in digital angiocardiography1988
Progress in digital angiocardiography1988
AbstractAbstract
[en] Cine CT is a new technology that allows for acquisition of high resolution tomographic images of cardiac structures allowing for precise measurements of global and regional cardiac function. This technology can be used in determining vein bypass graft patency and may be helpful in determining the flow reserve of bypass grafts and specific regions of the left ventricular myocardium. It is likely that information of this nature will be helpful in the care of patients with heart disease, and cine CT may find a place in the diagnostic evaluation of patients with cardiac disease. 11 refs.; 5 figs
Primary Subject
Source
Heintzen, P.H.; Buersch, J.H. (Kiel Univ. (Federal Republic of Germany) Dept. of Pediatric Cardiology and Biomedical Engineering) (eds.); Developments in cardiovascular medicine; no. 77; 365 p; ISBN 0-89838-965-8;
; 1988; p. 127-134; Kluwer; Dordrecht (Netherlands)

Record Type
Book
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] This chapter focusses on the methods used in cardiac MRI and some aspects of the underlying physics. (author). 29 refs.; 8 figs
Primary Subject
Source
Wall, E.E. van der; Roos, A. de (Rijksuniversiteit Leiden (Netherlands). Academisch Ziekenhuis) (eds.); Developments in Cardiovascular Medicine; v. 118; 296 p; ISBN 0-7923-0940-5;
; 1991; p. 81-95; Kluwer; Dordrecht (Netherlands)

Record Type
Book
Country of publication
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
Öz, Ahmet; Aruğaslan, Emre; Çınar, Tufan; Keskin, Muhammed; Hayıroğlu, Mert Ilker; Avşar, Şahin; Karataş, Mehmet Baran; Aydın, Berat Arıkan; Demir, Koray; Güngör, Barış; Bolca, Osman, E-mail: drozahmet@gmail.com2019
AbstractAbstract
[en] Some studies have been showed that electromechanical delay, which may pose an increased tendency to atrial fibrillation, may prolong in patients with various clinical conditions. In addition, the electromechanical delay in patients with secundum type atrial septal defect (ASD) compared to healthy people have been reported previously. Therefore, in the present study, we prospectively evaluated the mid-term and long-term effects of the transcatheter closure of secundum type ASD on the lateral atrial conduction time (PA), septal PA, tricuspid PA, left and right intra-atrial electromechanical delay (ILeft-EMD and IRight-EMD, respectively) and inter-atrial electromechanical delay (IA-EMD) measured by means of Doppler echocardiography. Our prospective study included a total of 45 secundum type ASD patients who undergone percutaneous transcatheter closure from December 2012 to April 2015. All patients underwent transthoracic echocardiography (TTE) before the closure, at sixth and twelfth months after the closure. In comparison of the EMD sixth months after the device closure, there were statistically significant decrease in lateral PA, septal PA, tricuspid PA, ILeft-EMD, IRight-EMD and IA-EMD compared to pre-device closure values. Twelfth months after the device closure, we also observed statistically significant decrease in lateral PA, septal PA, tricuspid PA, ILeft-EMD, IRight-EMD and IA-EMD compared to 6-month post-device closure values. In the present study, we observed that the atrial EMD improves after device closure and continues to improve after twelfth month following post-device closure.
Primary Subject
Source
Copyright (c) 2019 Springer Nature B.V.; Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
International Journal of Cardiovascular Imaging; ISSN 1569-5794;
; v. 35(1); p. 33-39

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Vorwerk, D., E-mail: Dierk.Vorwerk@klinikum-ingolstadt.de2012
AbstractAbstract
No abstract available
Primary Subject
Source
Copyright (c) 2012 Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Picano, E., E-mail: picano@ifc.cnr.it
Justification of Medical Exposure in Diagnostic Imaging. Proceedings of an International Workshop2011
Justification of Medical Exposure in Diagnostic Imaging. Proceedings of an International Workshop2011
AbstractAbstract
[en] The medical imaging market comprises several billion tests per year worldwide, and at least one-third of these are cardiovascular procedures. Keeping in mind that each test represents a cost, often a risk, and a diagnostic hypothesis, we must agree that every unnecessary and unjustifiable test is one test too many. Small individual costs, risks, and waste multiplied by billions of examinations per year become an important population, societal and environmental burden. (author)
Primary Subject
Source
International Atomic Energy Agency, Division of Radiation, Transport and Waste Safety, Vienna (Austria); European Commission, Brussels (Belgium); 190 p; ISBN 978-92-0-121110-1;
; Dec 2011; p. 59-66; International Workshop on Justification of Medical Exposure in Diagnostic Imaging; Brussels (Belgium); 2-4 Sep 2009; ISSN 0074-1884;
; Also available on-line: http://www-pub.iaea.org/MTCD/Publications/PDF/Pub1532_web.pdf; Enquiries should be addressed to IAEA, Marketing and Sales Unit, Publishing Section, E-mail: sales.publications@iaea.org; Web site: http://www.iaea.org/books; 5 figs, 1 tab, 31 refs


Record Type
Book
Literature Type
Conference
Country of publication
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
External URLExternal URL
AbstractAbstract
No abstract available
Primary Subject
Source
Copyright (c) 2013 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Liu, Fayuan; Chu, Chong; Wei, Qinyu; Shi, Jiawei; Li, Huadong; Dong, Nianguo, E-mail: lihuadong.416@163.com, E-mail: Dongnianguo@hotmail.com2018
AbstractAbstract
[en] Highlights: • β-catenin mediates TGF-β–induced osteoblastic differentiation of human AVICs. • Metformin ameliorates osteoblastic differentiation of AVICs by activating AMPKα. • Smad2/3 and JNK signaling mediates TGF-β1–induced activation of β-catenin in AVICs. • Metformin mitigates TGF-β1–induced β-catenin signaling by inhibiting Smad2/3 and JNK. Osteoblastic differentiation of aortic valve interstitial cells (AVICs) is the central process in the development of calcific aortic valve disease (CAVD). Metformin is a widely used first-line antidiabetic drug, and recently, pleiotropic benefits of metformin beyond hypoglycemia have been reported in the cardiovascular system. Here, we examined the effect of metformin on the osteoblastic differentiation of human AVICs. Our results showed that metformin ameliorated TGF-β1–induced production of osteogenic proteins Runx2 and osteopontin as well as calcium deposition in the cultured human AVICs. Experiments using AICAR, Compound C and AMPKα siRNA showed that the beneficial effect of metformin on TGF-β1–induced osteoblastic differentiation of human AVICs was mediated by AMPKα. Moreover, metformin inhibited the TGF-β1–induced activation of β-catenin, and β-catenin siRNA blocked TGF-β1–induced osteoblastic differentiation of AVICs. Smad2/3 and JNK were phosphorylated to promote the TGF-β1–induced activation of β-catenin and osteoblastic differentiation of AVICs, and metformin also alleviated TGF-β1–induced activation of Smad2/3 and JNK. In conclusion, our results suggest a beneficial effect of metformin based on the prevention of osteoblastic differentiation of human AVICs via inhibition of β-catenin, which indicates the therapeutic potential of metformin for CAVD.
Primary Subject
Source
S0006291X18309227; Available from http://dx.doi.org/10.1016/j.bbrc.2018.04.141; Copyright (c) 2018 Elsevier Inc. All rights reserved.; Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
Biochemical and Biophysical Research Communications; ISSN 0006-291X;
; CODEN BBRCA9; v. 500(3); p. 710-716

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
No abstract available
Primary Subject
Source
Copyright (c) 2013 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
1 | 2 | 3 | Next |